Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 801 results for "edwards lifesciences"

Edwards Lifesciences Shares Climbing Higher, Up 2.2%

One of today's stocks on the move is Edwards Lifesciences (NYSE:EW), up 2.2% to $145.53. The Dow Jones Industrial Average is now trading 0.3% lower to 17,681 and the S&P is trading 0.3% lower, 2 hours ago

34 images for edwards lifesciences

Broadway World, 1 week ago
WMBF, 2 weeks ago
PR Newswire, 2 weeks ago
SPi World News, 1 week ago
Nasdaq, 1 week ago
American Banking News, 1 month ago
The Malaysian Times, 2 weeks ago
One News Page United Kingdom, 1 month ago, 3 weeks ago
Seeking Alpha, 1 month ago

Morgan Stanley Overweight Edwards Lifesciences, Potential Product Markets Are Enormous

In a report published Monday, Morgan Stanley analyst David R. Lewis upgraded the rating on Edwards Lifesciences Corp (NYSE: EW) from Equal-Weight to Overweight, while raising the price target from $135 to $168. The analyst believes that the aortic ...
 Benzinga.com7 hours ago Morgan Stanley Upgrades Edwards Lifesciences To Overweight  Fat Pitch Financials6 hours ago Edwards Lifesciences Corp Upgraded at Morgan Stanley (EW)  SleekMoney7 hours ago Edwards Lifesciences Corp Rating Increased to Outperform at BMO Capital Markets (EW)  Mideast Time3 weeks ago
SPi World News

Top Analysts Actions: DEO, EW, TDW, ZINC, HUM

Diageo plc (NYSE: DEO) Nomura raises rating to buy from neutral Edwards Lifesciences (NYSE: EW) Morgan Stanley raises to overweight from equal-weight Tidewater (NYSE: TDW) Tudor Pickering lowers to hold from accumulate Horsehead Holding ...
 BayStreet.ca3 hours ago Edwards Lifesciences Corp Assigned A- Credit Rating by Morningstar (EW)  WKRB News3 days ago UPDATE - Edwards Lifesciences Chooses Selectica SmartContracts(R) Solution  Wall Street Select1 week ago Edwards Lifesciences Choses Selectica SmartContracts(R) Solution  SPi World News1 week ago

Edwards Lifesciences (EW) Showing Bullish Technicals With Resistance At $146.14

Jul 06, 2015 ( via COMTEX News Network) -- After closing Thursday at $142.45, Edwards Lifesciences Corp ( EW ) presents an attractive opportunity to get a 6.50% return in just 137 days, which is an annualized return of ...
 PredictWallStreet7 hours ago Edwards Lifesciences (EW) Showing Resistance Near $144.79  Individual.com4 days ago Edwards Lifesciences (EW) Showing Support Near $140.31  Individual.com4 days ago

Potential Edwards Lifesciences (EW) Trade Has 5.55% Downside Protection

Option-trade picking algorithms patented by found a trading opportunity with Edwards Lifesciences Corp ("EW) that should provide a 4.13% return in just 52 days. Sell one ...
 Individual.com6 days ago
Seeking Alpha

FDA clears Sapien 3 for high-risk TAVR patients

The FDA approved the third-generation transcatheter aortic valve replacement (TAVR) device by Edwards Lifesciences, giving the company permission to market the Sapien 3 system as a treatment for high-risk patients with severe aortic stenosis. ...
 Cardiovascular Business2 weeks ago TAVI Approvals Just The Latest From More Relaxed FDA  Seeking Alpha1 week ago Edwards Sapien 3 TAVR Approved Earlier than Expected  Medical Device & Diagnostic Industry2 weeks ago TAVI: Medtronic wins patent spat with doc inventor  MassDevice1 week ago

11-K - Edwards Lifesciences Corp (0001099800) (Filer)

Document Format Files Seq Description Document Type Size 1 11-K ew11-k2014puertoricoplan.htm 11-K 286522 2 EXHIBIT 23 ex-2311xk2014puertoricoplan.htm EX-23 4231 Complete submission text file
 SEC1 week ago

Buyers Accumulate Shares of Edwards Lifesciences, Up 1.2%

Edwards Lifesciences (NYSE:EW) is a company whose shares are active, trading 1.5% higher to $146.47. The Dow is trading fractionally lower to 18,112 and the S&P is currently trading fractionally lower
 Individual.com1 week ago

Edwards Lifesciences Fulfills the Promise: Up 0.5% Since Last Week's Upgrade

(Financial News Network On) BMO Capital upgraded Edwards Lifesciences (NYSE:EW) from Market Perform to Outperform a week ago. Edwards Lifesciences stocks closed at $133.60, a 0.5% gain over the course of one week. Edwards Lifesciences Corporation ...
 Individual.com2 weeks ago Edwards Lifesciences In Retrospect: Shares Up 0.5% Since Upgraded One Week Ago (EW)  Individual.com2 weeks ago

Edwards Lifesciences (EW) Trading Near $134.87 Resistance Level

FridayaEUR(TM)s trading in Edwards Lifesciences Corp ("EW) gives options traders an opportunity for a 7.53% return. By selling the Aug. '15 $130.00 call and buying the Jan. '16 call at the $100.00 ...
 Individual.com3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - edwards lifesciences
Get updated on latest news & your favorite topics right in your inbox!
More     Less